Danielle Brandman, MD, MAS

Associate Professor

Education
02/2020 - Diversity, Equity, and Inclusion Champion Training, University of California
Fellowship, 2012 - Transplant Hepatology, University of California, San Francisco
M.A.S. in Clinical Research, 2011 - Advanced Training in Clinical Research, University of California, San Francisco
Fellowship, 2011 - Gastroenterology, University of California, San Francisco
Residency, 2008 - Internal Medicine, University of California, San Francisco
Honors and Awards
  • Resident Mentor of the Year, CTSI Resident Research Program, 2016
  • Haile T. Debas Academy of Medical Educators, Excellence in Teaching Award, UCSF, 2015
Publications
  1. Brandman D, Boyle M, McPherson S, Van Natta ML, Sanyal AJ, Kowdley K, Neuschwander-Tetri B, Chalasani N, Abdelmalek MF, Terrault NA, McCullough A, Bettencourt R, Caussy C, Kleiner DE, Behling C, Tonascia J, Anstee QM, Loomba R. Letter: non-invasive prediction models to exclude cirrhosis in NAFLD-not everyone fits the mould. Authors' reply. 2022. PMID: 35689309


  2. Brandman D, Boyle M, McPherson S, Van Natta ML, Sanyal AJ, Kowdley K, Neuschwander-Tetri B, Chalasani N, Abdelmalek MF, Terrault NA, McCullough A, Bettencourt R, Caussy C, Kleiner DE, Behling C, Tonascia J, Anstee QM, Loomba R, Members of the Nonalcoholic Steatohepatitis Clinical Research Network. Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD). 2022. PMID: 35302256


  3. Rinella ME, Satapathy SK, Brandman D, Smith C, Elwir S, Xia J, Gibson M, Figueredo C, Angirekula M, Vanatta JM, Sarwar R, Jiang Y, Gregory D, Agostini T, Ko J, Podila P, Gallo G, Watt KD, Siddiqui MS. Factors impacting survival in those transplanted for NASH cirrhosis: Data from the NailNASH Consortium. 2022. PMID: 35189388


  4. Bond AR, Bainbridge E, Doernberg SB, Babik JM, Miller S, Khanafshar E, Henry T, David A, Russell M, Brandman D, Sherman CB, Yao F, Fung M. Disseminated Legionella micdadei Infection in a Liver Transplant Patient Presenting as Pulmonary Nodules and a Laryngeal Lesion. 2021. PMID: 33434394


  5. Price JC, Brandman D. Updated Hepatitis C Virus Screening Recommendation-A Step Forward. 2020. PMID: 32119030


  6. Siddiqui MS, Yamada G, Vuppalanchi R, Van Natta M, Loomba R, Guy C, Brandman D, Tonanscia J, Chalasani N, Neuschander-Tetri B, Sanyal AJ. Diagnostic Accuracy of Non-Invasive Fibrosis Models to Detect Change in Fibrosis Stage. 2019. PMID: 30616027


  7. Siddiqui MS, Vuppalanchi R, Van Natta ML, Hallinan E, Kowdley KV, Abdelmalek M, Neuschwander-Tetri BA, Loomba R, Dasarathy S, Brandman D, Doo E, Tonascia JA, Kleiner DE, Chalasani N, Sanyal AJ. Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease. 2018. PMID: 29705261


  8. Kushner T, Shinkai K, Fox L, Ying D, Gross A, Balitzer D, Gill R, Brandman D. New presentation of autoimmune hepatitis with erythema multiforme. 2018. PMID: 29059460


  9. Vuppalanchi R, Siddiqui MS, Van Natta ML, Hallinan E, Brandman D, Kowdley K, Neuschwander-Tetri BA, Loomba R, Dasarathy S, Abdelmalek M, Doo E, Tonascia JA, Kleiner DE, Sanyal AJ, Chalasani N. Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease. 2017. PMID: 28859228


  10. Lewin SM, Mehta N, Kelley RK, Roberts JP, Yao FY, Brandman D. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma. 2017. PMID: 28340509


  11. D. Brandman, M. Boyle, S. McPherson, M. Van Natta, A. Sanyal, K. Kowdley, B. Tetri, N. Chalassani, M. Abdelmalek, N.A. Terrault, A. McCullough, R. Bettencourt, C. Caussy, D. Kleiner, C. Behling, E. Doo, J. Tonascia, Q. Anstee, R. Loomba. PS-124 Comparison of clinical prediction rules for detection of cirrhosis in non-alcoholic fatty liver disease: a multicenter, international, collaborative study- NASH CRN (USA) and Newcastle (UK) Cohort. 2017. PMID:


  12. S. Epstein, D. Brandman, J. Dodge, J. Roberts, N. Terrault. Body Mass Index (BMI) and Survival After Liver Transplantation LT): Influence of the Extremes of BMI. 2014. PMID:


  13. Brandman D, Bacchetti P, Ayala CE, Maher JJ, Khalili M. Impact of insulin resistance on HCV treatment response and impact of HCV treatment on insulin sensitivity using direct measurements of insulin action. Volume 35 of Issue 5. 2012. PMID: 22399695


  14. Brandman D, Pingitore A, Lai JC, Roberts JP, Ferrell L, Bass NM, Terrault NA. Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus. 2011. PMID: 21770018


  15. Brandman D, Biggins SW, Hameed B, Roberts JP, Terrault NA. Pretransplant severe hepatic encephalopathy, peritransplant sodium and post-liver transplantation morbidity and mortality. 2011. PMID: 22098119


  16. Canuso CM, Goldstein JM, Wojcik J, Dawson R, Brandman D, Klibanski A, Schildkraut JJ, Green AI. Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. 2002. PMID: 12140115